SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-010197
Filing Date
2023-05-18
Accepted
2023-05-18 16:30:51
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20230331x10q.htm   iXBRL 10-Q 854434
2 EX-31.1 aptx-20230331xex31d1.htm EX-31.1 22959
3 EX-31.2 aptx-20230331xex31d2.htm EX-31.2 23121
4 EX-32.1 aptx-20230331xex32d1.htm EX-32.1 9963
  Complete submission text file 0001558370-23-010197.txt   4354129

Data Files

Seq Description Document Type Size
5 EX-101.SCH aptx-20230331.xsd EX-101.SCH 33470
6 EX-101.CAL aptx-20230331_cal.xml EX-101.CAL 40071
7 EX-101.DEF aptx-20230331_def.xml EX-101.DEF 123524
8 EX-101.LAB aptx-20230331_lab.xml EX-101.LAB 260114
9 EX-101.PRE aptx-20230331_pre.xml EX-101.PRE 220588
53 EXTRACTED XBRL INSTANCE DOCUMENT aptx-20230331x10q_htm.xml XML 723331
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 23936531
SIC: 2834 Pharmaceutical Preparations